Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Chierigo

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
World Journal of Urology|January 27, 2022
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patientsGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
The Journal of Urology|September 24, 2021
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate CancerFrancesco Chierigo, Mike Wenzel, Christoph Würnschimmel, et al.
The Prostate|May 31, 2021
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patternsChristoph Würnschimmel, Mike Wenzel, Francesco Chierigo, et al.
BJU International|July 4, 2024
Retzius-sparing robot-assisted radical prostatectomy with the Hugo™ robot-assisted surgery system: feasibility, operative setup and surgical outcomesPaolo Dell'Oglio, Francesco Chierigo, Valerio Cellini, et al.
Urologic Oncology|April 18, 2022
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicityGabriele Sorce, Francesco Chierigo, Rocco Simone Flammia, et al.
Prostate International|March 9, 2022
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancerBenedikt Hoeh, Rocco Flammia, Lukas Hohenhorst, et al.
The French Journal of Urology|June 26, 2026
Performance of Artificial Intelligence Chatbots Compared with Young Academic Urologists in Reconstructive UrologyAgate Escoffier, Oussama Hedhli, Felix Campos-Juanatey, et al.
The Prostate|October 18, 2021
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
International Urology and Nephrology|November 16, 2021
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patientsBenedikt Hoeh, Jan L Hohenhorst, Rocco Flammia, et al.
The Prostate|April 11, 2022
Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Gabriele Sorce, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
World Journal of Urology|January 27, 2022
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patientsGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
The Journal of Urology|September 24, 2021
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate CancerFrancesco Chierigo, Mike Wenzel, Christoph Würnschimmel, et al.
The Prostate|May 31, 2021
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patternsChristoph Würnschimmel, Mike Wenzel, Francesco Chierigo, et al.
BJU International|July 4, 2024
Retzius-sparing robot-assisted radical prostatectomy with the Hugo™ robot-assisted surgery system: feasibility, operative setup and surgical outcomesPaolo Dell'Oglio, Francesco Chierigo, Valerio Cellini, et al.
Urologic Oncology|April 18, 2022
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicityGabriele Sorce, Francesco Chierigo, Rocco Simone Flammia, et al.
Prostate International|March 9, 2022
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancerBenedikt Hoeh, Rocco Flammia, Lukas Hohenhorst, et al.
The French Journal of Urology|June 26, 2026
Performance of Artificial Intelligence Chatbots Compared with Young Academic Urologists in Reconstructive UrologyAgate Escoffier, Oussama Hedhli, Felix Campos-Juanatey, et al.
The Prostate|October 18, 2021
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patientsBenedikt Hoeh, Christoph Würnschimmel, Rocco S Flammia, et al.
International Urology and Nephrology|November 16, 2021
Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patientsBenedikt Hoeh, Jan L Hohenhorst, Rocco Flammia, et al.
The Prostate|April 11, 2022
Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Gabriele Sorce, et al.
Pageof 11